Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Completed · Phase 3

Conditions studied: HIV Infection

In brief

The purpose of this study is to obtain a preliminary assessment of the antiviral activity and tolerability of simplified Kaletra dual agent therapy as initial treatment for HIV infection, relative to a Kaletra three drug standard of care reference arm.

Key facts

Study ID

NCT00234910

Run by

Abbott

People needed

152

Starts

2005-01-01

Expected to finish

2008-06-01

Last updated by the study team

2008-07-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• HIV positive
• >18 years of age
• HIV RNA> 400 copies/mL
• Any CD 4 cell count
• Antiretroviral naïve
• No acute illness

Where it is running

• Global Medical Information-Abbott — Abbott Park, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.